Kabra Drugs Share Price

Kabra Drugs

CMP as on14-Jun-21 14:37

₹ 5.25
0.25 5%

Open

₹ 5.25

Turnover (lac)

Prev. Close

₹ 5.00

Day's Vol (shares)

₹ 2,123

Day's Range

₹ 5.25
₹ 5.25

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 12-Mar-2021 - -
KABRA DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/03/2021 ,inter alia, to consider and approve We would like to inform you that the Board Meeting of the Directors of the Company will be held on 19-03-2021 at the registered office of the Company at 4.00 PM for the following Agenda. 1. To discuss about business expansion and road map for future growth. 2. To discuss about fund raising through Right Issue / Preferential Allotment / Convertible debenture 3. Any other Agenda with the permission of the chair. We would like to inform you that the Board Meeting of the Directors of the Company has authorized Mr. R. Muralidharan (Director) to look into business expansion and road map for future growth and fund raising through Right Issue / Preferential Allotment / Convertible debenture (As Per BSE Announcement dated on 19.03.2021)
Board Meeting - 02-Feb-2021 - -
KABRA DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2021 ,inter alia, to consider and approve Pursuant to Regulation 29(1) (a) & (2) of the SEBI (LODR) Regulations, 2015, notice is hereby given that a Meeting of the Board of Directors of the Company will be held on Saturday, February 13, 2021 at 12.30 P.M. to consider and approve, inter-alia, the Un-Audited Financial Results of the Company for the quarter ended on December 31, 2020
Board Meeting - 04-Nov-2020 - -
KABRA DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2020 ,inter alia, to consider and approve Pursuant to Regulation 29(1) (a) & (2) of the SEBI (LODR) Regulations, 2015, notice is hereby given that a Meeting of the Board of Directors of the Company will be held on Friday, November 13th, 2020 at 12.30 P.M. to consider and approve, inter-alia, the Un-Audited Financial Results of the Company for the quarter ended on September 30, 2020 Further, the Trading Window for dealing in shares of the Company is already closed and shall open 48 hours after conclusion of the Board Meeting.
Board Meeting - 07-Sep-2020 - -
Quarterly Results
Board Meeting - 27-Aug-2020 - -
KABRA DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2020 ,inter alia, to consider and approve With reference to the above subject, we are pleased to inform you that a meeting of the Board of Directors of the Company will be held on Wednesday, 02nd September, 2020, at the Registered Office of the Company. I am directed to inform that the meeting of the Board of Directors of the Company was held on 2nd September, 2020, and following business was transacted, inter alia, at the meeting of the Board of Directors: (AS Per BSE Announcement Dated on 02.09.2020)
Board Meeting - 02-Jul-2020 - -
KABRA DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/07/2020 ,inter alia, to consider and approve In accordance with provision of Regulation of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015, notice is hereby given that a Meeting of the Board of Directors of the Company will be held on Thursday, July 9th, 2020 at 12.30 P.M. to consider and approve, inter-alia, 1. Set up of Corporate office at Bangalore and Marketing office at Chennai. 2. Any other Agenda with the permission of the chair.
Board Meeting - 22-Jun-2020 - -
KABRA DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2020 ,inter alia, to consider and approve Meeting of the Board of Directors of the Company will be held on Tuesday, June 30th , 2020 at 12.30 P.M. to consider and approve, inter-alia, the Audited Financial Results along with the statement of Assets & Liabilities of the Company for the quarter and year ended on March 31, 2020 Outcome of the Board Meeting- audited financial results for 4th Quarter and financial year ended 31st March, 2020 (As Per BSE Announcement Dated 30.06.2020)
Open ZERO Brokerage Demat Account